Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Comment by AngelMan92on Jul 09, 2020 12:39pm
76 Views
Post# 31245994

RE:# of Tests

RE:# of TestsI follow your kind of logic, as well as my experience in the field. Rapid expansion shouldn't be a problem if everything is already there. If they are under 250 tests per day, it would be borderline lying to the investors.
Liked2Think wrote: Everyone has lower expectations as number of tests but I dont.

They have said they could do 1,000 a day since the start of testing.  Yeah I know they dont start out at that day one and they need supplies and what not but if by the end of July if they are not doing 1,000 a day (AKA their "capacity") then WTF are they doing.

If you have that capacity with an accurate test during this period of history how can you not be maxing out.  It should be like having water in the desert.  A license to print money.

If they cant sell covid testing then we have no hope in them selling aristotle which has obviously been the problem with colonsentry and the others up until now.

I still dont understand relying on the PP to decide how many people you hire to do covid testing.

If you truly have the demand then what is the risk in hiring more people to supply more tests.


Bullboard Posts